Literature DB >> 16509813

Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment.

Carmine Gazzaruso1.   

Abstract

The current review reports recent data available in the literature on the prevalence of erectile dysfunction and the association of erectile dysfunction with overt and silent coronary artery disease in patients with diabetes mellitus. The mechanisms by which erectile dysfunction is associated with coronary artery disease and potential clinical implications of this association have been extensively analysed. In particular, the role of endothelial dysfunction in the pathophysiology of erectile dysfunction and the potential clinical usefulness of erectile dysfunction to identify diabetic patients with silent coronary artery disease have been outlined. Finally, recent guidelines on the treatment of erectile dysfunction with phosphodiesterase-5 inhibitors in diabetic patients with and without coronary artery disease have been reported and discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16509813     DOI: 10.1586/14779072.4.2.173

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  5 in total

1.  Erectile dysfunction in stroke patients: a multifactorial problem with important psychosocial consequences.

Authors:  Kosmas I Paraskevas; Nikolaos Bessias; Polyvios Pavlidis; Dimitrios Maras; Theofanis T Papas; Christos D Gekas; Vassilios Andrikopoulos
Journal:  Int Urol Nephrol       Date:  2008-08-06       Impact factor: 2.370

2.  Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetes.

Authors:  Carmine Gazzaruso; Adriana Coppola; Arturo Pujia; Colomba Falcone; Silvia Collaviti; Mariangela Fodaro; Pietro Gallotti; Sebastiano B Solerte; Andrea Giustina; Gabriele Pelissero; Livio Luzi; Tiziana Montalcini
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

3.  Traditional Chinese medicine on treating diabetic mellitus erectile dysfunction: Protocol for a systematic review and meta-analysis.

Authors:  Xudong D Yu; Jisheng S Wang; Guang Zuo; Xin Wang; Fuxing Ge; Songli Wu; Jingyang Lim; Jianwei Shang; Yaosheng Zhang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

4.  Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality.

Authors:  Simon G Anderson; David C Hutchings; Mark Woodward; Kazem Rahimi; Martin K Rutter; Mike Kirby; Geoff Hackett; Andrew W Trafford; Adrian H Heald
Journal:  Heart       Date:  2016-07-26       Impact factor: 5.994

5.  Intracavernous Injection of Platelet-Rich Plasma Therapy Enhances Erectile Function and Decreases the Mortality Rate in Streptozotocin-Induced Diabetic Rats.

Authors:  Chun-Hou Liao; Kau-Han Lee; Shiu-Dong Chung; Kuo-Chiang Chen; Chellappan Praveen Rajneesh; Bo-He Chen; Jai-Hong Cheng; Wang-Ying Lin; Han-Sun Chiang; Yi-No Wu
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.